Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.

Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G.

Mol Cancer. 2011 Sep 30;10:124. doi: 10.1186/1476-4598-10-124.

2.

DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.

Foltz G, Yoon JG, Lee H, Ryken TC, Sibenaller Z, Ehrich M, Hood L, Madan A.

Oncogene. 2009 Jul 23;28(29):2667-77. doi: 10.1038/onc.2009.122.

PMID:
19465937
3.

Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.

Rajendran G, Shanmuganandam K, Bendre A, Muzumdar D, Goel A, Shiras A.

J Neurooncol. 2011 Sep;104(2):483-94. doi: 10.1007/s11060-010-0520-2. Erratum in: J Neurooncol. 2011 Sep;104(2):495. Mujumdar, Dattatreya [corrected to Muzumdar, Dattatraya].

PMID:
21229291
4.

Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.

Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P.

Oncogene. 2012 Dec 6;31(49):5108-16. doi: 10.1038/onc.2011.660.

PMID:
22286769
5.

CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma.

Xiaoping L, Zhibin Y, Wenjuan L, Zeyou W, Gang X, Zhaohui L, Ying Z, Minghua W, Guiyuan L.

Cell Death Dis. 2013 Jun 20;4:e675. doi: 10.1038/cddis.2013.197.

6.

Frequent epigenetic inactivation of the SLIT2 gene in gliomas.

Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F.

Oncogene. 2003 Jul 17;22(29):4611-6.

PMID:
12881718
7.
8.

Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.

Costello JF, Berger MS, Huang HS, Cavenee WK.

Cancer Res. 1996 May 15;56(10):2405-10.

9.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.

Oncogene. 2003 Jul 17;22(29):4509-16.

PMID:
12881707
10.

The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.

Szenthe K, Koroknai A, Banati F, Bathori Z, Lozsa R, Burgyan J, Wolf H, Salamon D, Nagy K, Niller HH, Minarovits J.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):489-95. doi: 10.1016/j.bbrc.2013.03.022.

PMID:
23528241
11.

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.

Schirmer U, Fiegl H, Pfeifer M, Zeimet AG, Müller-Holzner E, Bode PK, Tischler V, Altevogt P.

BMC Cancer. 2013 Mar 26;13:156. doi: 10.1186/1471-2407-13-156.

12.

Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas.

Qu M, Jiao H, Zhao J, Ren ZP, Smits A, Kere J, Nistér M.

Neuropathol Appl Neurobiol. 2010 Apr;36(3):198-210. doi: 10.1111/j.1365-2990.2010.01070.x.

PMID:
20132488
13.

Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.

Zhang Z, Li D, Wu M, Xiang B, Wang L, Zhou M, Chen P, Li X, Shen S, Li G.

BMC Mol Biol. 2008 Nov 3;9:99. doi: 10.1186/1471-2199-9-99.

14.

Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.

Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP.

PLoS Genet. 2007 Oct;3(10):2023-36.

15.

Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.

Gao J, Chen T, Liu J, Liu W, Hu G, Guo X, Yin B, Gong Y, Zhao J, Qiang B, Yuan J, Peng X.

Glia. 2009 Jul;57(9):989-99. doi: 10.1002/glia.20823.

PMID:
19062177
16.

DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells.

Zschocke J, Allritz C, Engele J, Rein T.

Glia. 2007 May;55(7):663-74.

PMID:
17311293
17.

Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.

Wee EJ, Peters K, Nair SS, Hulf T, Stein S, Wagner S, Bailey P, Lee SY, Qu WJ, Brewster B, French JD, Dobrovic A, Francis GD, Clark SJ, Brown MA.

Oncogene. 2012 Sep 20;31(38):4182-95. doi: 10.1038/onc.2011.584.

18.

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D.

Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.

19.

LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.

Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G, Wu M.

Curr Cancer Drug Targets. 2012 Oct;12(8):1032-42.

PMID:
22834685
20.

DNA methylation and cancer.

Kulis M, Esteller M.

Adv Genet. 2010;70:27-56. doi: 10.1016/B978-0-12-380866-0.60002-2. Review.

PMID:
20920744
Items per page

Supplemental Content

Support Center